NLS Pharmaceutics (NCEL) Earnings (2018 - 2025)
NLS Pharmaceutics (NCEL) earnings from Dec 31, 2018 to Dec 31, 2025. The TTM NLS Pharmaceutics (NCEL) earnings is -$8.30M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
NLS Pharmaceutics (NCEL) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +15.28% |
| 3 Years | -20.47% |
| 5 Years | +23.75% |
| All Time | +7.06% |
Annual Earnings change of NLS Pharmaceutics (NCEL)
| Year | Earnings | Change |
|---|---|---|
| 2025 | -$8.30M | +15.28% |
| 2024 | -$7.20M | +116.22% |
| 2023 | -$3.33M | -79.82% |
| 2022 | -$17M | +38.08% |
| 2021 | -$12M | +317.83% |
| 2020 | -$2.86M | -47.52% |
| 2019 | -$5.45M | +5.83% |
| 2018 | -$5.15M | N/A |
Comparison NLS Pharmaceutics (NCEL) five years earnings CAGR with competitors
NLS Pharmaceutics (NCEL) five years earnings CAGR is 23.74%.